Plaque Psoriasis Resources
Chosen by Advanced
Practice Providers
  • Clinical guidelines
  • Patient support and education resources
  • Research updates
Tuberculosis (TB) remains a significant global health issue, especially for individuals with latent tuberculosis infection (LTBI). Current evidence suggests that IL-17 and IL-23 inhibitors, used to treat conditions...
CURATED BY: Leigh Ann Pansch,
MSN, FNP-BC, DCNP

Bimekizumab Shows Low Risk of Suicidal Ideation and Depression in Psoriasis Patients

Patients with psoriasis have an increased risk of suicidal ideation and behavior (SIB) and depression. Bimekizumab, an interleukin (IL)-17A and...
CURATED BY:
Renee Ott,
MSN, CNP

Psoriasis Linked to Higher Risk of Lung and Breast Cancer

Psoriasis, a chronic inflammatory skin disease affecting about 3% of the population, has been linked to an increased risk of...
CURATED BY:
Alison Kortz,
PA-C

Research Identifies Hormone Hepcidin as Key Trigger in Psoriasis

Recent research suggests that the hormone hepcidin may be a key factor in triggering psoriasis, a chronic skin disease affecting...
CURATED BY:
Alison Kortz,
PA-C

Physician Associate and Nurse Practitioner Contributors to the Plaque Psoriasis Center of Excellence

POCN’s Plaque Psoriasis Center of Excellence is curated by nurse practitioners and practicing clinical physician associates who select only the most impactful resources for their peers. Designed to empower providers like you with the latest insights and tools, our experts ensure each resource is practical, current, and highly relevant to your practice and patient care.

Provided by an unrestricted grant from

Share